Global Over-the-Counter (OTC) Veterinary Drugs Market Poised for Remarkable Growth with a Projected CAGR of 7.9% from 2023 to 2033

The global over-the-counter (OTC) veterinary drugs market is on the verge of substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 7.9% from 2023 to 2033. According to recent market analysis, the industry is set to achieve an impressive market share of USD 19.01 billion by 2033, a significant rise from its estimated value of USD 8.8 billion in 2023.

This rapid expansion of the OTC veterinary drugs market is largely attributed to the rising adoption of dogs and cats as beloved family members, a trend that has surged in the post-pandemic era. As more people integrate pets into their households, there is an increasing focus on their nutrition, health, and overall well-being. This evolving pet ownership dynamic is driving the demand for OTC veterinary drugs, which are favored for their convenience and accessibility.

A key factor fueling the market’s growth is the trend among pet owners seeking easy-to-access solutions for their pets’ health needs. The convenience of obtaining OTC veterinary drugs without the need for a veterinarian’s prescription has led to a notable increase in their use. This shift is further supported by recent regulatory changes that have made OTC veterinary drugs more widely available. With evolving legal frameworks promoting self-care for pets, consumers now enjoy greater access to a broader range of veterinary products, simplifying the procurement process and enhancing pet care.

The OTC veterinary drugs market is set to thrive as these trends continue to shape the industry, offering pet owners an accessible and convenient option for maintaining their pets’ health and well-being.

Key Takeaways:

  • The United States market leads the over-the-counter (OTC) veterinary drugs market in terms of market share in North America. The United States region held a market share of 25.6% by 2022. The growth in this region is attributed to higher pet adoption and government efforts. North America dominates the market as it held a 35% global share in 2022.
  • Germany’s over-the-counter (OTC) veterinary drugs market is another significant market in the European region. The market held a market share of 7.9% in 2022. The growth is attributed to the presence of the major OTC veterinary drug producers. Europe held a global share of 32% in 2022.
  • The Indian over-the-counter (OTC) veterinary drugs market thrives at a CAGR of 8.3% during the forecast period. The booming growth rate is attributed to the increasing pet adoption and humanization along with the increasing number of OTC veterinary drug producers in the region.
  • The oral form segment leads the dosage form type segment as it held a market share of 76.40% in 2022. The growth is attributed to lower pain unlike injections, higher effectiveness, and affordability.
  • Based on the sales channel type, the online pharmacies segment leads as it held a market share of 40% in 2022. The growth is attributed to easy shipping and higher availability.

Access the Full Report: Find Detailed Analysis on the Over-The-Counter (OTC) Veterinary Drugs Market

Competitive Landscape:

The key vendors work on a smaller number of side effects, enhanced supply chain, and higher affordability.  Companies also collaborate to expand their supply chain. Key competitors and also merge, acquire, and partner with other companies to increase their supply chain, and distribution channel.

Recent Market Development:

  • Boehringer Ingelheim has introduced new products such as aftopor/aftovaxpur/aftovax, Arti-Cell FORTE, Aservo EquiHaler, and Bovela. and dairy cattle.
  • Phibro Animal Health Corporation has revisited their OTC veterinary drugs for swine, beef cattle.

Key Players:

  • Zoetis
  • Boehringer Ingelheim
  • Virbac S.A.
  • Hester Biosciences Ltd.
  • Merck Animal Health
  • Elanco Animal Health
  • Ceva Santé Animale
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • Kyoritsu Seiyaku Corporation
  • AlphaVet Animal Health Ltd.
  • AdvaCare Pharma
  • Alphafacts Health Solution
  • Bimeda Animal Health Inc.

Key Segments Covered:

By Drug Class:

  • NSAIDs
  • Antihistamines
  • Decongestants & Bronchodilators
  • Antibacterial
  • H2 Receptor Antagonists
  • Nutrients & Supplements
  • Glucocorticoids
  • Lubricant eye drops & artificial tears
  • Anti-parasitic
  • Antidiarrheal agents
  • Others

By Product Form:

  • Oral
  • Injectable
  • Topical
  • Others

By Sales Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Hypermarkets & Supermarkets
  • Online Pharmacies
  • Veterinary Shops

Key Regions Covered:

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Citrus Fiber Market to Reach USD 248.6 Million by 2034, Driven by Consumer Shift Towards Natural Products | FMI

Picture background

The citrus fiber market is predicted to be valued at US$ 172.7 million in 2024 and is expected to reach US$ 248.6 million by 2034, marking a CAGR of 3.7%. The upsurge in product acceptance and usage is the factor accountable for the market growth during the forecast period.

The new fiber enrichment technology helps in making the citrus fiber penetrate industrial use. Furthermore, no chemical modification in the citrus fiber products also pushes the end users to use citrus fiber.  Naturally derived citrus fiber is in high demand as it is preferred by the industries that produce chemical-free drinks and beverages.

Better skin and clearer blood are other merits of citrus fiber, along with its application in pharmaceuticals. Vendors process the citrus with advanced technologies that involve mixing, milling, heating, and drying. The advanced procedure also works in the direction of limiting the waste to the minimum while creating opportunities for other industries to use pure citrus fiber. From soluble to insoluble, citrus fiber provides clean label ad nutritive properties to baked goods.

The major application of citrus fiber in creating beverage ingredient solutions as it provides high water-holding capacity and emulsification properties to deliver a sustainable process and composition also helps the market growth.

Key Points

  • The US market is the biggest space for the pet care industry and is anticipated to cross a value of US$ 40.8 Mn by 2033. The regional market is expected to thrive at an elevated 5.9% between 2023 and 2033.
  • The South Korean market thrives at the highest CAGR of 6% during the forecast period. The market is likely to reach a value of US$ 5.5 Mn by 2033.
  • The food grade segment is likely to thrive in the grade category because of the higher consumption of citrus fiber in various food cuisines and packaged items. It is expected to thrive at a CAGR of 4.8% during the forecast period.
  • The orange segment thrives the highest in the source type segments, with a CAGR of 5.5% between 2023 and 2033, while it thrived at a lower CAGR of 4.3% during the historical period.

Competitive Landscape

Key competitors focus on delivering the most organic citrus fiber to industrial end users. The wide range of applications pushes vendors to adopt techniques to deliver a better and dimension-specific proportion of citrus fiber solutions. Key players in the market are Fiberstar, Inc, CEAMSA, CP Kelco, Inc, Herbafoods Ingredients GmbH, Florida Food Products, Inc, Lemont, Golden Health, FUYAN PHARM (Henan), Inc, Nans Products, and Cifal Herbal Private Ltd.

For instance:

  • Herbafoods Ingredients GmbH has extended its product chain by introducing 100% citrus fiber that is textured, stabilized, and emulsified. The product comes with fruit-specific flavour and aroma and moderate water-binding capacity.
  • CP Kelco, Inc has introduced its nature-based raw citrus fiber named NUTRAVA, which is clean label-friendly citrus for multi-industrial usage.

Detailed Market Breakdown: Comprehensive Full Report

Key Segments

By Grade:

  • Food Grade
  • Pharmaceutical Grade
  • Cosmetic Grade

By Source:

  • Orange
  • Tangerine/Mandarins
  • Grapefruit
  • Lemons and Lime

By Application:

  • Bakery
  • Desserts and Ice-cream
  • Sauces & Seasonings
  • Meat & Egg Replacement
  • Beverages
  • Flavorings & Coatings
  • Snacks & Meals
  • Personal Care
  • Pharmaceutical
  • Other Application

By Function:

  • Water Binder & Fat Replacer
  • Thickening Gums
  • Gelling Gums
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

 Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Viral Vector Development Market Set for Exceptional Growth, Projected to Reach USD 4.1 Billion by 2033

The global viral vector development market is on the brink of extraordinary expansion, driven by significant advancements in gene therapy and vaccine development. According to a recent study published by Future Market Insights, the market is projected to soar to USD 4.1 billion by 2033, with a remarkable Compound Annual Growth Rate (CAGR) of 18.7%.

By the end of 2023, the market is anticipated to hit a notable milestone, reaching USD 730.7 million. This impressive growth trajectory highlights the increasing adoption of viral vectors in therapeutic applications, reflecting a burgeoning interest in innovative treatments and technologies.

Adeno-associated viral vectors (AAV) are identified as key drivers of this growth. By the end of 2023, AAVs are expected to dominate the market, commanding a significant share of approximately 37.0%. Their unparalleled versatility in gene therapy and vaccine development makes them indispensable tools in the biopharmaceutical industry.

“The exponential growth of the viral vector development market underscores the escalating demand for cutting-edge treatments and vaccines,” remarked a Future Market Insights. “AAVs, in particular, are transforming the landscape by enabling precise delivery and enhancing therapeutic efficacy.”

The study emphasizes the critical role of technological advancements and strategic collaborations in propelling market expansion. With increasing investments and research initiatives, stakeholders are well-positioned to seize emerging opportunities, driving unprecedented growth in the viral vector development sector.

Key Takeaways:

  • Gene therapy is vital to repair suppressed and malfunctioning genes in human cells or tissues and helps in returning the abnormality to a normal level. Viral vector technology is commonly utilized to cultivate the gene. Furthermore, this business has grown for many private players. For the most part, two different types of techniques are used to use viral vectors in the gene therapy-induced healing process.
  • When it comes to 2D planer technologies, scaling out of adherent cell systems is one of the common strategies that is applied until the point of market analysis. The production of suspension AAV by diverse segments will, therefore, rely increasingly on 3D suspension cell cultures or bioreactors in the upcoming period.
  • The propelling synthesis of viral vectors utilizing cell culture technology has been modified successfully in order to satisfy the demands of both early and advanced clinical trial Scale-up, however, may still be constrained depending on the vector type and the cell culture production platforms chosen.
  • At present, visible progress is being made within the generation of cell lines that are able to create inducible or constitutively expressed lentiviral vectors that grow in suspension. Over the past few years, the first batch of lentiviral vectors generated by reliable producer cell lines was utilized in a clinical trial setting.
  • With extensive safety and efficiency, the data gathered from numerous clinical trials show that gene therapy is making great progress. These factors are set to promote the expansion of the global market, over the forecast period.

Reveal Market Insights: Download the Complete Viral Vector Development Market Report

Competitive Landscape:

Over recent years, the market for the production of plasmid DNA and viral vector CDMO has become extremely competitive. This has resulted in the introduction of numerous companies in these industries. The main tactic used by the leading firms to stay ahead of their rivals is the expansion of production facilities. A cost-effective strategy for the rapid expansion and capacity building for viral vector process development for the manufacturers is the acquisition of small regional companies.

Key Companies Covered:

  • Thermo Fisher Scientific Inc
  • Charles River (Cobra Biologics)
  • NOVASEP
  • uniQure N.V
  • Waisman Biomanufacturing
  • Creative Biogene
  • GenScript Biotech Corporation
  • Novartis AG
  • Merck KGaA
  • Takara Bio, Inc.
  • FUJIFILM Diosynth Biotechnologies
  • LONZA
  • Danaher Corp. (Aldevron)
  • Sirion Biotech GmbH
  • AGC Biologics

More Insights into the Viral Vector Development Market:

The North American region is anticipated to dominate the global viral vector development market over the assessment period as it accounted for a total of 33.1% in 2022. The USA is expected to continue to grow its dominance in the global market within the next decade.

Key Market Segments Covered in Viral Vector Development Industry Research

Virus:

  • Lentiviral Vectors
  • Adenoviral Vectors
  • Adeno-Associated Viral Vectors
  • Retrovirus

Expression System:

  • Transient
  • Stable

Application:

  • Gene Therapy
  • Vaccines
  • Cancer Therapy
  • Others

End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Contract Research Organization (CRO)
  • Academic and Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cow Colostrum Industry to Expand to USD 2.8 Billion by 2033, According to Future Market Insights, Inc.

The cow colostrum market is experiencing a surge in demand as consumers are becoming increasingly aware of the remarkable health benefits it offers. Colostrum, the “first milk” produced by cows shortly after giving birth, is a nutritional powerhouse packed with immune-boosting antibodies, growth factors, and essential nutrients. This natural elixir has gained popularity for its potential to enhance immunity, aid in digestion, and promote overall well-being.

The expected value of the cow colostrum industry in 2022 is USD 1.40 billion. Cow colostrum is used as a nutritive supplement to aid athletes in developing their immune systems and muscles. By 2023, it is anticipated to have made USD 2.8 billion, with a CAGR of 6.5% from 2023 to 2033.

The market is growing more quickly as a result of athletes’ increased use of cow colostrum, which decreases damage to the upper respiratory system and intestines. Cow colostrum is a supplement that is growing popular among athletes since it helps the athlete’s overall immune system. The cow colostrum market is expected to expand over the span of the projection because of the increasing athletic consumption of cow colostrum.

The anti-ageing benefits of cow colostrum, which help to reduce facial wrinkles, are thought to help the product’s market expansion. Growth hormone from the colostrum promotes both cell regeneration as well as skin cell formation, which increases the suppleness and the thickness of the skin. The claim that bovine colostrum has anti-aging qualities is anticipated to boost market sales throughout the anticipated period.

A growing variety of cutting-edge methods have been established in the last several years to produce goods containing cow colostrum. Colostrum powders that dissolve quickly and are ready to combine were among the new goods that hit the market, and their widespread use has increased.

Key Takeaways from the Market Study

  • Sales of cow colostrum increased by 5.4% CAGR between 2018 and 2022.
  • Over 86% of the worldwide market for traditional cow colostrum is accounted for by rising demand in developed and emerging nations.
  • B2B will have a 51.29% market share as a share of value in 2022 and is predicted to expand at a 4.63% CAGR over the forecast period.
  • The market for finished goods made from cow colostrum will account for 56.5% of the total market in 2022.
  • With a predicted market share of around 61.2% in 2022, the United States is predicted to have the highest share of cow colostrum in North America.
  • In South Asia, India holds a 25.4% market value share and is projected to increase at a CAGR of 8.21%.

“The market for cow colostrum is expanding because of the product’s high protein content and immunity-boosting qualities in its nutritional profile. Taking supplements made from cow colostrum can boost immunity and promote improved intestinal health.” remarks an FMI analyst.

Competitive Landscape

It is anticipated that the demand for cow colostrum will rise in the near future for use in animal feed ingredients. Strong promotional and marketing campaigns are a crucial opportunity for businesses to increase their reach and share of the market in the cow colostrum industry since informative colostrum advertising is a particular field that has been discovered to be missing.

Prominent players in the cow colostrum market are:

  • Colostrum BioTec GmbH
  • Zuche Pharmaceuticals
  • Biodane Pharma A/S
  • Agati Healthcare Pvt. Ltd.
  • McePharma
  • Cure Nutraceuticals Pvt. Ltd.
  • Ingredia Nutritional (Ingredia S.A.)
  • Sterling Technology
  • Biotaris B.V.
  • La Belle Inc.
  • Now Health Group, Inc.
  • The Saskatoon Colostrum Company
  • Good Health New Zealand

Some key developments of the leading companies in this market are:

  • Dutch company Biotaris B.V. has provided premium cow as well as goat colostrum goods for many years. Their colostrum products surpass the usual quality criteria thanks to the development of a unique cold-state manufacturing technology to process raw colostrum deeper in a loss-free and friendly manner.
  • In 2021, Bioblock, a unique nasal spray containing antibodies towards the SARS-CoV-2 virus generated from cow colostrum, is being sold on Tallink Grupp’s Estonian boats.
  • A pioneer in nutrition as well as biotechnology, PanTheryx, announced the release of three product formulations such as cow colostrum in March 2021. These include baked nutrition bars, soft chews, and soft presses.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global cow colostrum market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the cow colostrum market, the market is segmented on the basis of cow colostrum by nature (organic, conventional), product type (whole, colostrum finished products), end use (B2B, B2C) and across five major regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

Comprehensive Industry Report: A Full Market Analysis

Key Segments Profiled in the Global Cow Colostrum Market

Nature:

  • Organic
  • Conventional

Product Type:

  • Whole
    • Whole Colostrum Powder
    • Skim Colostrum Powder
    • Specialty Colostrum Powder
  • Colostrum Finished Products
    • Capsules
    • Chewable Tablets
    • Individual Sachets
    • Specially Formulated Products

End Use:

  • B2B
    • Dietary Supplements
    • Sports Nutrition
    • Functional Foods
    • Animal Nutrition
    • Cosmetics
    • Infant Formula
    • Pharmaceuticals
  • B2C
    • Hypermarket/Supermarket
    • Convenience Store
    • Specialty Stores
    • Drug Stores
    • Health & Wellness Stores
    • Online Retailing

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Clinical Nutrition Market Poised for Significant Growth, Expected to Surge to USD 29.2 Billion by 2033, Reports Future Market Insights

Future Market Insights (FMI), a leading provider of market research and consulting services, has unveiled its latest findings on the global clinical nutrition market, forecasting a robust growth trajectory in the coming years. According to FMI’s comprehensive analysis, the market is on track to achieve a remarkable milestone, reaching USD 13.4 billion by 2023 and anticipated to surge further to USD 29.2 billion by 2033. This represents a substantial compound annual growth rate (CAGR) of 8.1%.

The burgeoning demand for clinical nutrition solutions is attributed to several key factors. Consumers are increasingly acknowledging the critical role of nutrition in maintaining overall health, which has led to heightened awareness and a growing preference for specialized clinical nutrition products tailored to specific health needs. Additionally, the global aging population significantly contributes to market expansion. Clinical nutrition products play a pivotal role in managing chronic health conditions and enhancing well-being among older adults, thereby fueling market growth.

“We are witnessing a transformative phase in the clinical nutrition market,” stated a FMI. “The convergence of heightened consumer awareness and the demographic shift towards an aging population underscores the immense growth potential for specialized nutritional products.”

FMI’s report highlights that North America currently dominates the clinical nutrition market, driven by advanced healthcare infrastructure and widespread adoption of innovative nutritional therapies. However, the Asia Pacific region is poised to emerge as a lucrative market opportunity, supported by increasing healthcare expenditure and rising awareness of preventive healthcare measures.

As the global clinical nutrition market continues to evolve, stakeholders across the healthcare spectrum are encouraged to capitalize on emerging trends and innovations to meet the growing demand for effective nutritional solutions.

Key Takeaways:

  • Adults are leading the consumer segment with a growth of 7.8%. Adults are now more prone to chronic diseases due to their unhealthy choices and sedentary lifestyles.
  • Cancer leads the application segment with a rate of 7.6%. A cancer patient is highly vulnerable to malnutrition, which can cause nutritional deficiencies and can severe the patient’s condition. To overcome this, proper and planned nutrition is required along with the therapies.
  • The United Kingdom holds a leading position in the European clinical nutrition industry with a growth rate of 7.2% due to the high prevalence of chronic diseases, the growing elderly population, and the rising frequency of metabolic disorders.
  • The United States holds a prominent share of the market contributing revenue of USD 9.4 billion by 2033. This region has high obesity rates among other regions which is a key factor for the development of the market
  • China market is growing at an impressive rate of 7.5%. Diabetes is the most prevalent disease in the region which creates a significant need for proper nutrition. Growing awareness among the people is estimated to further provide lucrative opportunities in the region.

Get Old Source Presents the Latest Reports

Competitive Landscape:

Prominent firms in the sector are implementing strategic plans like boosting output and broadening their global footprint. For instance, the dairy cooperative Laita’s ESI Nutrition division announced in May 2020 that the Ploudaniel facility has the first commercial plant and a new manufacturing line that is completely operational. Additionally, ESI Nutrition sought to increase the variety of formats clients could choose from, so it introduced two new, smaller-than-usual container sizes: 70 ml and 90 ml. These are transparent to monitor consumption levels and ergonomically constructed to make them easy to manage.

Latest Developments:

  • To provide customized nutrition solutions to the South Korea market, Hologram Sciences and Maeil Health Nutrition partnered in October 2022.
  • In April 2022, Glanbia Nutritionals introduced TechVantage, a platform for nutrient technology that has been functionally improved, and offers customers nutrient solutions.

Key Players:

Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo are some of the key players in clinical nutrition market.

Key Segments Covered in the Clinical Nutrition Market Report:

By Product:

  • Infant Nutrition
  • Parenteral Nutrition

By Application:

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

By Distribution Channel:

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others

By Consumer:

  • Pediatric
  • Adult

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Nutraceutical Gummies Industry Insights: Comprehensive Growth and Regional Trends Analysis Through 2033

Picture background

The nutraceutical gummies market is anticipated to exceed a valuation of US$ 99.4 billion in 2033. According to Future Market Insights, a US$ 29.1 billion is likely for the market in 2023. From 2023 to 2033, the market for nutraceutical gummies is projected to escalate at an impressive CAGR of 13.4%.

Nowadays, to maintain their health and reduce their risk of sickness, customers are considering purchasing products rich in essential nutrients such as vitamins and minerals. This is a primary driver of the market for nutraceutical gummies, which are more convenient, portable, and tasty compared to traditional health supplements.

Several nutraceutical gummies manufacturers are choosing online platforms for the advertising and sale of their products owing to rising internet penetration and payment flexibility. FMI expects social media marketing to be at the forefront of key players’ efforts for encouraging the consumption of their products among their respective target audiences.

Key Takeaways from the Nutraceutical Gummies Market Study

  • In the North America market for nutraceutical gummies, the United States is likely to lead the way between 2023 and 2033.
  • Spain is set to emerge as one of the dominant markets in Europe from 2023 to 2033.
  • In Asia, India is poised to contribute significantly to market expansion.
  • A valuation of US$ 29.1 billion is expected for the global market for nutraceutical gummies in 2023.
  • In 2033, FMI expects the market to be valued at US$ 99.4 billion following acceleration at a 4% CAGR from 2023 to 2033.

“The global market is projected to benefit from the rising self-diagnosis trend among consumers. It is also anticipated that the consumption of nutraceutical gummies will see an increase because of the fitness culture amongst the youth and the nutritional values it provides.” Says an FMI Analyst

Who is Winning?

Several top manufacturers of nutraceutical gummies are concentrating on providing cost-effective products owing to their increasing demand from consumers. Different companies have implemented integrated production approaches to delivering value-for-money products in the market to escalate their industry footprints and to upsurge their production capacities. Prominent players of nutraceutical gummies are investing in research & development to produce their offerings in a more organic way and with lesser use of artificial flavoring and chemicals.

Leading players operating in the market for nutraceutical gummies include Zarbee’s, Inc., Bayer AG, Nature’s Bounty Co., Sanofi S.A., SmartyPants Vitamins, Otsuka Holdings Co. Ltd., Olly Public Benefit Corporation, Church & Dwight Co. Inc., The Honest Company, Inc., Nature’s Way, Pfizer, and, Life Science Nutritionals.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the Nutraceutical Gummies Market, presenting historical demand data (2018 to 2022) and forecast statistics for the period from 2023 to 2033. The study divulges compelling insights on the nutraceutical gummies market based on nutritional class (vitamin & minerals, dietary fiber, prebiotics & probiotics, polyunsaturated & fatty Acids, and antioxidants), functionality (digestive health, Immunity & strength, cardiovascular health, bone & muscles health), age (pediatric, geriatric, and adult), and distribution channel (hospital pharmacies, retail pharmacies, drugstores, supermarkets, and online stores) across seven regions.

About the Food & Beverage Division at Future Market Insights

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Complete Market Review: A Full Report Analysis

Global Nutraceutical Gummies Market by Category

By Nutritional Class:

  • Vitamin & Minerals
    • B Complex
    • Vitamin C
    • Calcium & Vitamin D
    • Milk Minerals
    • Iron
  • Dietary Fiber
  • Prebiotics & Probiotics
  • Polyunsaturated & Fatty Acids
  • Antioxidants

By Functionality:

  • Digestive Health
  • Immunity & Strength
  • Cardiovascular Health
  • Bone & Muscles Health

By Age:

  • Paediatric
  • Geriatric
  • Adult

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drugstores
  • Supermarkets
  • Online Stores

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fish Protein Market Expected to Expand at 7.2% CAGR Through 2033, per FMI

Picture background

The fish protein market is valued at USD 1 billion in 2023 and is projected to double and reach USD 2 billion by 2033. The market is expected to register a CAGR of 7.2%, during the forecast period.

The plethora of nutritional benefits offered by fish protein has made it a favorite amongst health-conscious consumers. Government initiatives and subsidies to boost aquaculture have also been acting in the market’s favor. FMI’s analysis predicts a favorable period for key players. On the other hand, the time is ripe for new players to step in and conquer the market by filling technological gaps.

Developed markets have emerged as the most lucrative ones, due to consumer penchant for innovative products. New variants of over-the-counter fish protein health supplements are swarming the north American and European markets. Modern lifestyle habits and poor diet has inspired consumers to look for a quick fix. On the other hand, the beauty industry is harnessing the potency of the product to launch new formulations such as nutricosmetics.

Further, key players have been striving to capture market demand, through the adoption of technologies that hasten the fish growth cycle. This is extremely beneficial in augmenting production capacities. Since demand is currently on the rise, key players must attempt not to be bogged down by market restraints such as high production, storage, and transportation costs.

Key Takeaways from the Report:

  • According to FMI’s analysis, fish protein market sales have grown at a CAGR of 6.1% between 2017 and 2022.
  • The U.S. fish protein market is to rise at a CAGR of 8% to reach USD 566.4 Mn by 2033.
  • India’s fish protein market is expected to grow at 6% CAGR during the forecast period.
  • Between 2023-2033 the South Korean market is expected to rise at a CAGR of 6.1% to reach a valuation of UD 64.2 Mn by 2033.
  • During the forecast period, the powder segment is expected to grow at a CAGR of 7.4% as the top form.
  • The fish protein isolate segment is projected to grow at a CAGR of 6.6% during the forecast period. It is currently, the most in-demand segment, by product type.

Key Players Diversify to Capture Consumer Attention

Key players are launching a variety of products, especially in the pharmaceuticals sector to sustain market growth. Further, to stay abreast of current trends, many are launching, sustainable and organically sourced variants to meet market demands. To slash competition, top players are investing in advanced technologies to yield higher-quality products in a shorter time span.

Key Market Developments:

  • In 2021, Avant Meats Company Limited acquired Vinh Hoan Corporation, a renowned producer of seafood and protein. This was to bolster the commercialization of fish protein by expanding the global sales network and production capacities.
  • In 2022, Paine and partners sold its subsidiary, ScanBio to two companies namely Pioneer Infrastructure and Verdane. Pioneer Infrastructure is based in the UK, whereas Verdane is based in Norway. Pain and partners officially acquired ScanBio in 2011.

Key Market Players:

  • Omega Proteins
  • Bio-Oregon Protein
  • Colpex International Inc.
  • Mukka Seafood Industries Limited
  • Aroma NZ
  • Ingredients Inc.
  • Peterlabs Holdings
  • Siam Industries International
  • Apelsa Guadalajara S.A. de C.V.
  • Bio Phoenix Formulations
  • Qingdao Future Group

Full Market Assessment: Comprehensive Report

Fish Protein Market by Category

Form:

  • Powder
  • Liquid

Product Type:

  • Fish Protein Concentrate
  • Fish Protein Isolate
  • Fish Protein Hydrolysate

Application:

  • Food & Beverages
  • Cosmetics and Personal Care
  • Sports Nutrition & Dietary Supplement
  • Pharmaceuticals
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global In Vitro Diagnostics Market Set to Reach USD 129.9 Billion by 2033, Fuelled by Technological Innovations and Rising Demand

The global in vitro diagnostics market is experiencing an unprecedented surge, driven by groundbreaking innovations and a growing demand for advanced diagnostic solutions. According to recent industry analyses and projections, the market is poised to achieve a remarkable milestone, reaching an estimated USD 129.9 billion by 2033. This trajectory reflects a robust Compound Annual Growth Rate (CAGR) of 4.8%, building upon a solid foundation of USD 81.3 billion in 2023.

The continuous evolution and adoption of cutting-edge diagnostic technologies are reshaping the global healthcare landscape. These advancements empower medical professionals with unparalleled precision and efficiency in disease diagnosis, significantly enhancing patient care outcomes.

Transformative Wave of Innovation

The remarkable growth of the global IVD market signifies a paradigm shift in healthcare delivery, with advanced technologies playing a crucial role in shaping the future of diagnostics. From molecular diagnostics to innovative point-of-care testing solutions, the industry is witnessing a transformative wave of innovation aimed at addressing unmet medical needs and improving patient outcomes.

Key factors contributing to this projected growth include:

  • Advancements in Technology: Continuous innovation in diagnostic tools and methods.
  • Rising Prevalence of Chronic and Infectious Diseases: Increasing demand for effective diagnostic solutions.
  • Growing Geriatric Population: Higher need for routine diagnostics and monitoring.
  • Adoption of Point-of-Care Testing: Enhanced accessibility and immediate results.
  • Personalized Medicine Approaches: Tailored diagnostic solutions to individual patient needs.

“The anticipated surge in the in vitro diagnostics market signifies an exciting era in healthcare,” stated Future Market Insights. “This growth reflects the pivotal role these diagnostics play in improving patient outcomes, optimizing treatment decisions, and revolutionizing disease management strategies.”

Future Prospects and Market Dynamics

The projected growth aligns with the rising focus on preventive healthcare measures, heightened patient awareness, and supportive government initiatives aimed at enhancing diagnostic infrastructure and accessibility. Major players and emerging companies are expected to intensify their research and development efforts, introducing innovative diagnostic tools and solutions to drive the market forward.

As the market continues to evolve, the IVD sector is set to make significant strides, ensuring a dynamic and progressive landscape for healthcare providers and patients alike. The commitment to innovation and improving global healthcare standards will undoubtedly shape a promising future for the in vitro diagnostics market.

Key Points:

  • The United States market leads the space in terms of market share. The market is expected to cross a value of USD 51.9 billion by 2033. The regional market is expected to thrive at a CAGR of 4.4% between 2023 and 2033.
  • The Indian in vitro diagnostics market leads in terms of CAGR. It thrives at a steady CAGR of 8.8% during the forecast period. The market is likely to reach a value of USD 5.6 billion by 2033. Asian economies like India and China building their healthcare infrastructure by advancing them with the latest diagnostics solutions for early detection and faster prevention.
  • Clinical chemistry is likely to thrive in the technology-type category as it covers massive diagnostic operations along with the prevention of life-threatening cancers. It is expected to thrive at a CAGR of 4.2% during the forecast period.
  • The infectious disease segment tops the application category with a CAGR of 4.6% between 2023 and 2033. The growth is attributed to higher consumption.

Get Old Source Has the Newest Reports Available

Competitive Landscape:

The key competitors focus on developing efficient, faster, and effective detection technology. Key competitors also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market are: Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Abbott, Thermo Fisher Scientific

For Instance:

  • Roche diagnostics has introduced its in vitro diagnostics (IVDs) that are to cover conditions and infections through blood tissue and urine. Furthermore, advanced diagnostic tools are launched by the company.
  • Thermo Fisher Scientific has introduced its testing categories such as advanced instruments and automation technology, disease diagnostic, quality controls, and quality assurance software.

Key Segments:

By Product & Service:

  • Reagents
  • Instruments
  • Services & Software

By Technology:

  • Immunodiagnostics
  • Hematology
  • Molecular diagnostics
  • Tissue diagnostics
  • Clinical chemistry
  • Others

By Application:

  • Infectious diseases
  • Cancer
  • Cardiac diseases
  • Immune system disorders
  • Nephrological diseases
  • Gastrointestinal diseases
  • Others

By End User:

  • Standalone laboratories
  • Hospitals
  • Academics & Medical Schools
  • Point-of-Care
  • Others

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Asian Sea Bass Market Poised to Grow to USD 1.57 Billion by 2034, FMI Analysis Reveals

Picture background

The market for Asian sea bass is estimated to reach US$ 1,012 million by 2024. A CAGR of 4.5% will be achieved by 2034, bringing sales to US$ 1,567 million. Lates calcarifer, also known as giant perch or barramundi, is commonly known as Asian sea bass. Among the Indo-Pacific nations, it is one of the most valuable fish cultivated in the country.

Various studies reveal that sea bass is an excellent source of omega-3 fatty acids, which is one of the most important nutrients to maintain cardiovascular health, as it decreases inflammation, lowers blood pressure, and lowers the risk of heart disease. Its nutritional content makes sea bass an excellent source of health benefits.

Sea bass contains a high amount of protein, which supports a healthy immune system, prevents imbalances in hormone levels, and supports the functioning of the body’s tissues. In addition to Omega 3 and Omega 6 vitamins, sea bass also contains minerals like magnesium and selenium, which are essential for healthy bones, strong immune systems, and energy production.

The omega-3 fatty acids present in sea bass may also enhance memory and focus in addition to enhancing the brain health and cognitive function of the fish. With its anti-inflammatory properties, sea bass might lower the risk of conditions such as arthritis, cardiovascular disease, and some types of cancer by aiding in the body’s fight against chronic inflammation.

In terms of eye health, sea bass is a good choice. As a great source of vitamins and nutrients, it contains important nutrients like vitamin A, and omega-3 fatty acids, and it protects the retina from damage, thus preventing age-related macular degeneration and supporting healthy eyes.

Key Takeaways from the Market Study

  • 45% of the market is expected to be occupied by farmed products in 2024.
  • Based on form, the whole segment market share is expected to reach 25% in 2024.
  • India is predicted to experience a 4.2% CAGR during the forecast period.
  • The United Kingdom is expected to drive Asian sea bass demand by 9.3% CAGR during the forecast period.
  • With 3.4% of the market, China will become a lucrative market for Asian sea bass.

“Increasing awareness about the nutritional value of sea food among consumers and advances in aqua farming are likely to drive demand for Asian sea bass. Increasing regulations and consumer demand for organic farming will drive demand for the market in the future,” comments a Future Market Insights analyst.

Competitive Landscape

Asian sea bass products are effective at increasing consumer awareness and driving demand through a variety of marketing techniques. Partnerships with businesses and food outlets, as well as participation in seafood trade shows, are all contributing to higher brand awareness.

  • In December 2022, Singapore-based Barramundi Group formed a partnership with Wild Ocean Australia. The Barramundi Group developed the Kimberley Ocean Barramundi Project following its partnership with Wild Ocean.

More Valuable Insights Available

Future Market Insights offers an unbiased global Asian sea bass market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034

To understand market opportunities, the Asian sea bass market is segmented based on the source (farmed (freshwater, brakishwater) and wild)), form (whole, headed and gutted, fillet, and frozen), sales channel (direct sales-B2B, and retail sales (modern trade, convenience store, specialty food stores, online retail, and others)) and region (North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, Middle East and Africa).

Extensive Market Research: Complete Report and Findings

Asian Sea Bass – Key Segments

By Source:

Market segments include farmed (freshwater, brakishwater) and wild.

By Form:

Key sourcing data is in the report, such as whole, headed and gutted, fillet, and frozen.

By Sales Channel:

Formats are further divided into direct sales-B2B and retail sales (modern trade, convenience store, specialty food stores, online retail, and other).

By Region:

The market has been analyzed in the major markets of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, and Middle East & Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Telehealth and Telemedicine Market Set to Skyrocket, Projected to Reach USD 912.0 Billion by 2033

The global telehealth and telemedicine market is experiencing unprecedented growth, with market projections indicating a surge from USD 106.0 billion in 2023 to an astounding USD 912.0 billion by 2033. This significant expansion, representing a Compound Annual Growth Rate (CAGR) of 24%, underscores the transformative impact of telehealth solutions on the future of healthcare.

The rising adoption of telehealth and telemedicine is driven by a confluence of factors reshaping the healthcare landscape. A marked increase in the demand for mental health services and chronic pain management has emerged as a critical driver, fueled by a growing global awareness of mental health issues. Moreover, cutting-edge innovations in healthcare technology, including advanced diagnostic tools and AI-driven chatbots, are revolutionizing patient care, further propelling the demand for telehealth services.

Cost-efficiency is another pivotal factor in this growth trajectory. Healthcare providers worldwide are increasingly adopting telehealth platforms to enhance medical services while reducing costs. This trend is particularly evident in the growing demand for telehealth solutions in radiological diagnostics, spurred by the rising incidence of heart-related issues and orthopedic injuries.

Government initiatives play a crucial role in creating a conducive environment for the telehealth market’s expansion. Efforts to strengthen healthcare infrastructure and promote digital diagnostic devices have been instrumental in accelerating the adoption of telehealth services. The convenience of accessing both mental and physical healthcare consultations remotely has also significantly contributed to the widespread embrace of telehealth among patients.

The market’s robust growth is further evidenced by the continuous expansion of advanced diagnostic laboratories and healthcare providers globally. Government investments in telecommunication solutions are facilitating seamless online connections between patients and healthcare professionals, thereby enhancing market opportunities.

As the telehealth and telemedicine sector continues to evolve, stakeholders are well-positioned to leverage the ongoing technological advancements. The focus remains on driving innovation and improving patient outcomes, solidifying telehealth’s pivotal role in the future of global healthcare delivery.

Benefits for Patients and Providers:

The burgeoning telehealth and telemedicine market offers a multitude of advantages for both patients and healthcare providers:

  • Enhanced Patient Access: Patients in remote locations or with mobility limitations will have improved access to quality healthcare services.
  • Increased Convenience: Telehealth consultations offer greater flexibility for patients, allowing them to schedule appointments around their busy schedules.
  • Improved Cost-Effectiveness: Telehealth can significantly reduce healthcare costs associated with travel and in-person consultations.
  • Streamlined Care Delivery: Healthcare providers can leverage telehealth to expand their reach, improve patient engagement, and deliver care more efficiently.

The Future of Healthcare:

The phenomenal growth of the telehealth and telemedicine market underscores its position as a cornerstone of modern healthcare. As technology continues to evolve, we can expect even more innovative solutions to emerge, further revolutionizing the way healthcare is delivered and experienced.

Key Takeaways:

  • The telehealth and telemedicinemarket are expected to have a valuation of USD 0 billion by 2033.
  • With a CAGR of 3.1%, the global market is increasing from 2022 to 2033.
  • The United States telehealth and telemedicine marketis anticipated to expand at a CAGR of 23.8% through 2033.
  • With a CAGR of 23.0%, the United Kingdom market significantly uplifts during the forecast period.
  • China market is expected to secure a CAGR of 23.3% over the forecast period.
  • Japan market captured a CAGR of 22.3% from 2023 to 2033.

Get the Entire Market: Download the Complete Telehealth and Telemedicine Market Report

Other Key Players in the Market are:

  • Medtronic
  • Allscripts Healthcare Solutions Inc
  • GE Healthcare
  • Siemens Healthineers
  • Cerner Corporation
  • BioTelemetry
  • Koninklijke Philips NV

Recent Developments in the Telehealth and Telemedicine Market is:

  • In July 2021, Estshara invested USD 5,00,000 to provide telepharmacy services and online consultations to patients.
  • In May 2021, Teladoc Health announced its partnership with Vivo to enhance the quality of healthcare services through telemedicine in Brazil.
  • In Dec 2021, BioTelemetry announced an agreement to merge with Royal Philips to advance its portfolio.

Telehealth and Telemedicine Market segmentation by Category:

By Component:

  • Software & Services
  • Hardware

By Mode of Delivery:

  • Cloud-based
  • On-premise

By Application:

  • Teleconsultation
  • TeleICU
  • Telestroke
  • Teleradiology
  • Telepsychiatry
  • Teledermatology
  • Other Applications

By End Use:

  • Providers
  • Patients
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube